Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

Indart AC, Lyu H, Nguyen VQ, Rosenthal W, Palvai JR, Jang SS, Chen Y, Jude K, Su L, Garcia KC, Bluestone JA, Tang Q

DOI: 10.1084/jem.20251480
Published: 2026 Sep 7
Container: The Journal of experimental medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1084/jem.20251480,
  title = {Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.},
  author = {Indart AC and Lyu H and Nguyen VQ and Rosenthal W and Palvai JR and Jang SS and Chen Y and Jude K and Su L and Garcia KC and Bluestone JA and Tang Q},
  year = {2026},
  journal = {The Journal of experimental medicine},
  doi = {10.1084/jem.20251480},
  url = {https://doi.org/10.1084/jem.20251480}
}

RIS

TY  - JOUR
TI  - Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.
AU  - Indart AC
AU  - Lyu H
AU  - Nguyen VQ
AU  - Rosenthal W
AU  - Palvai JR
AU  - Jang SS
AU  - Chen Y
AU  - Jude K
AU  - Su L
AU  - Garcia KC
AU  - Bluestone JA
AU  - Tang Q
PY  - 2026
JO  - The Journal of experimental medicine
DO  - 10.1084/jem.20251480
UR  - https://doi.org/10.1084/jem.20251480
ER  -

APA

AC, I., H, L., VQ, N., W, R., JR, P., SS, J., Y, C., K, J., L, S., KC, G., JA, B., & Q, T. (2026). Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.. The Journal of experimental medicine. https://doi.org/10.1084/jem.20251480

Source records

pubmed · retrieved 2026-09-26T00:31:10.976Z